Philip W. Brownjohn

852 total citations
13 papers, 482 citations indexed

About

Philip W. Brownjohn is a scholar working on Cellular and Molecular Neuroscience, Physiology and Pharmacology. According to data from OpenAlex, Philip W. Brownjohn has authored 13 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 6 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Philip W. Brownjohn's work include Cannabis and Cannabinoid Research (5 papers), Pain Mechanisms and Treatments (4 papers) and Transcranial Magnetic Stimulation Studies (3 papers). Philip W. Brownjohn is often cited by papers focused on Cannabis and Cannabinoid Research (5 papers), Pain Mechanisms and Treatments (4 papers) and Transcranial Magnetic Stimulation Studies (3 papers). Philip W. Brownjohn collaborates with scholars based in New Zealand, United Kingdom and France. Philip W. Brownjohn's co-authors include John C. Ashton, Frederick J. Livesey, Janelle Ashton, James Smith, John Hardy, Henry Houlden, Ebba Lohmann, Sabine Dietmann, Torsten Kleffmann and John N. J. Reynolds and has published in prestigious journals such as Endocrinology, Neuroscience and Journal of Histochemistry & Cytochemistry.

In The Last Decade

Philip W. Brownjohn

13 papers receiving 475 citations

Peers

Countries citing papers authored by Philip W. Brownjohn

Since Specialization

Citations

This map shows the geographic impact of Philip W. Brownjohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip W. Brownjohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip W. Brownjohn more than expected).

Fields of papers citing papers by Philip W. Brownjohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip W. Brownjohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip W. Brownjohn. The network helps show where Philip W. Brownjohn may publish in the future.

Co-authorship network of co-authors of Philip W. Brownjohn

This figure shows the co-authorship network connecting the top 25 collaborators of Philip W. Brownjohn. A scholar is included among the top collaborators of Philip W. Brownjohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip W. Brownjohn. Philip W. Brownjohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease 2024 ·Frontiers in Pharmacology ·Philip W. Brownjohn, Azedine Zoufir, Daniel J. O’Donovan, (unknown), (unknown), (unknown), John R. Porter, (unknown), (unknown), Neil T. Thompson	2
2	Tumour necrosis factor induces increased production of extracellular amyloid-β- and α-synuclein-containing aggregates by human Alzheimer’s disease neurons 2020 ·Brain Communications ·Daniel R. Whiten, Philip W. Brownjohn, Steven Moore, Suman De, (unknown), (unknown), Moritz Haneklaus, David Klenerman, Frederick J. Livesey	18
3	Functional Studies of Missense TREM2 Mutations in Human Stem Cell-Derived Microglia 2018 ·Stem Cell Reports ·Philip W. Brownjohn, James Smith, (unknown), Ebba Lohmann, Henry Houlden, John Hardy, Sabine Dietmann, Frederick J. Livesey	124
4	Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer’s Disease 2017 ·Stem Cell Reports ·Philip W. Brownjohn, James Smith, Erik Portelius, Lutgarde Serneels, Hlin Kvartsberg, Bart De Strooper, Kaj Blennow, Henrik Zetterberg, Frederick J. Livesey	51
5	Differences in Motor Evoked Potentials Induced in Rats by Transcranial Magnetic Stimulation under Two Separate Anesthetics: Implications for Plasticity Studies 2016 ·Frontiers in Neural Circuits ·(unknown), (unknown), Philip W. Brownjohn, Alexander D. Tang, Jennifer Rodger, Jonathan Shemmell, John N. J. Reynolds	31
6	Anxiogenic and Stressor Effects of the Hypothalamic Neuropeptide RFRP-3 Are Overcome by the NPFFR Antagonist GJ14 2015 ·Endocrinology ·Joon S. Kim, Philip W. Brownjohn, (unknown), Massimiliano Beltramo, Christopher S. Walker, Debbie L. Hay, Gavin F. Painter, Joel D. A. Tyndall, Greg M. Anderson	50
7	Effect of styrene maleic acid WIN55,212-2 micelles on neuropathic pain in a rat model 2014 ·Journal of drug targeting ·(unknown), Philip W. Brownjohn, (unknown), Khaled Greish, John C. Ashton	15
8	Validating Antibodies to the Cannabinoid CB2 Receptor 2014 ·Journal of Histochemistry & Cytochemistry ·Yannick Marchalant, Philip W. Brownjohn, Amandine Bonnet, Torsten Kleffmann, John C. Ashton	76
9	The Effects of Individualized Theta Burst Stimulation on the Excitability of the Human Motor System 2013 ·Brain stimulation ·Philip W. Brownjohn, John N. J. Reynolds, (unknown), (unknown), Jonathan Shemmell	33
10	Numerical modelling of plasticity induced by transcranial magnetic stimulation 2013 ·Journal of Computational Neuroscience ·Marcus T. Wilson, (unknown), Philip W. Brownjohn, Jonathan Shemmell, John N. J. Reynolds	18
11	The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain 2012 ·Neuroscience Letters ·Courtney Breen, Philip W. Brownjohn, John C. Ashton	15
12	Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury 2011 ·Neuroscience ·Philip W. Brownjohn, Janelle Ashton	45
13	Novel targets in pain research: The case for CB2 receptors as a biorational pain target 2009 ·Current Anaesthesia and Critical Care ·Philip W. Brownjohn, John C. Ashton	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact